Every Cat Logo

Grants

EC25S-074: Development of FIV Nanoblades as a genetic cure for FIV infection

Feline immunodeficiency virus (FIV) affects 5–20% of cats worldwide, causing a disease like human immunodeficiency virus (HIV) in humans (acquired immunodeficiency syndrome or AIDS). Unlike HIV, there are no approved treatments for FIV, so care is currently focused on managing symptoms rather than curing the disease. This study aims to develop a groundbreaking treatment option using gene-editing technology called CRISPR-Cas9 to target and remove FIV from infected cells.

Grant ID: EC25S-074

Status: Active

Year Funded: 2025

Amount awarded: $24,994

Investigator: Jolien Van Cleemput, Ghent University, Belgium